Norgine

NCT06593743

The Safety and Dose Response to Single Anal Doses of NRL001

NCT00856713

Clearance of NRL972 in Patients With Cirrhosis and in Healthy Volunteers

NCT00856752

Evaluation of the Pharmacokinetics of NRL972 Following Pre-Administration of Rifampicin and Cyclosporine

NCT00857480

Evaluation of the PK of NRL972 Following Pre- and co-Administration of Ursodeoxycholic Acid and Cloxacillin

NCT00896246

Scintigraphic Assessment Following Klean-Prep® or Moviprep®

NCT00893607

Effect of Single Doses of 10 mg NRL001 Applied as a Suppository to the Anal Canal or Rectum

NCT01406925

Safety and Tolerability of a Single Intra-anal Dose of NRL001 in Healthy Volunteers

NCT06593730

Safety and Tolerability of the Twice Daily Intra-anal Application of NRL001 Cream for 14 Days

NCT00868985

Effects of Oral PEG 3350 on Electrolyte Balance

NCT00850590

Study of Escalating Doses of NRL001 Given in Slow-release Rectal Suppositories of Different Weights

NCT00857467

Study to Investigate Safety and Response to 1 or 2 g Rectal Suppositories Containing 5 or 10 mg NRL001.

NCT00896597

Reproducibility of Child-Turcotte-Pugh (CTP) Rating and NRL972 Pharmacokinetics in Patients With Cirrhosis

NCT01099670

Safety, Tolerability, Pharmacodynamic and Pharmacokinetics of 7.5, 10, 12.5 or 15 mg NRL001 in a 2 g Suppository for 14 Days

NCT01099683

Safety, Tolerability, Pharmacodynamic and Pharmacokinetics of a Single Rectal Application of 10 mg NRL001 in Elderly Subjects

NCT01164332

Sensitivity of Alternative NRL972 Detection Methods in Healthy Subjects

NCT01175941

Effect of 7 Days of Dosing With a 10 mg Rectal Suppository of NRL001in Patients With Faecal Incontinence

NCT01710995

A Three-Period Study to Investigate the Relative Bioavailability and Pharmacodynamic Profiles of a Zegerid 20mg Capsule, Zegerid 20mg Powder for Oral Suspension and Losec 20mg Capsule in Healthy Adult Volunteers Under Fasting Conditions

NCT01834742

Pharmacodynamic Evaluation of Stool Output Following Oral Administration of Various Low Volume PEG3350-based Gut Cleansing Solutions Using the Split Dose Intake in Healthy Subjects

NCT01405599

Evaluation of the Pharmacokinetics of Ulimorelin in Subjects With Hepatic Impairment and Healthy Subjects

NCT01405612

Study to Examine the Effect of Ulimorelin on the Pharmacokinetics of Midazolam in Healthy Volunteers

NCT01668199

A Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery and Pharmacokinetics of 14C TZP-101

NCT01715272

A Clinical Investigation to Demonstrate the Performance of a New Enema (TF037) in Distal Bowel Cleansing Compared With Fleet Enema

NCT03437265

A Pharmacokinetic Study of PLENVU® in Healthy Subjects